# Boswellia Recovery Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/boswellia-recovery-meta-analysis-evidence-review
Category: evidence-review
Summary: Boswellia Recovery Meta-analysis has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed 
Last reviewed: 2026-08-20
Reviewed by: Migaku Evidence Review
# Boswellia Recovery Meta-analysis: What the Evidence Says

## Quick Answer

Boswellia Recovery Meta-analysis has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 observational study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy and Safety of Acmella oleracea and Boswellia serrata Extract as Add-On Therapy for Chronic Low Back Pain: An Observational, Real-World Cohort Study | observational study | 3 | 2025-12-17 | 10.3390/ph18121903 |

## What The Sources Report

- Current pharmacological treatments provide inconsistent long-term efficacy and are associated with significant side effects. [Giglio Mariateresa (2025); evidence level 3]
- Non-steroidal anti-inflammatory drugs (NSAIDs), though effective for inflammation, offer limited relief in CLBP with neuropathic components and may be associated with gastrointestinal, cardiovascular, and renal complications with prolonged use. [Giglio Mariateresa (2025); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For boswellia recovery meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Giglio Mariateresa (2025). Efficacy and Safety of Acmella oleracea and Boswellia serrata Extract as Add-On Therapy for Chronic Low Back Pain: An Observational, Real-World Cohort Study. DOI: 10.3390/ph18121903. PMCID: PMC12736306. PMID: 41471392. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12736306/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.